- Report
- November 2025
- 192 Pages
Global
From €3133EUR$3,545USD£2,760GBP
€3481EUR$3,939USD£3,067GBP
- Report
- December 2025
- 455 Pages
Global
From €5170EUR$5,850USD£4,554GBP
- Report
- January 2023
- 117 Pages
Global
From €3977EUR$4,500USD£3,503GBP
- Report
- April 2023
- 100 Pages
Global
From €4198EUR$4,750USD£3,698GBP
- Report
- July 2024
- 187 Pages
China
From €1591EUR$1,800USD£1,401GBP
- Report
- July 2024
- 326 Pages
China
From €3535EUR$4,000USD£3,114GBP
- Report
- November 2025
- 132 Pages
Global
From €840EUR$950USD£740GBP
The Smallpox Vaccine is a vaccine used to prevent smallpox, a highly contagious and potentially fatal disease caused by the variola virus. The vaccine is made from a weakened form of the virus, which stimulates the body's immune system to produce antibodies that protect against the disease. The vaccine was first developed in 1796 by Edward Jenner, and has since been used to eradicate smallpox from the world.
The Smallpox Vaccine market is a subset of the larger Vaccines market, which includes a wide range of vaccines used to prevent a variety of diseases. The Smallpox Vaccine market is relatively small, as the disease has been eradicated and the vaccine is no longer widely used. However, the vaccine is still used in certain circumstances, such as for people who are at high risk of exposure to the virus.
Some companies in the Smallpox Vaccine market include Sanofi Pasteur, Merck & Co., GlaxoSmithKline, and Pfizer. Show Less Read more